Reclast and Dermatitis allergic - a phase IV clinical study of FDA data

Summary:

Dermatitis allergic is reported only by a few people who take Reclast.

The phase IV clinical study analyzes which people take Reclast and have Dermatitis allergic. It is created by eHealthMe based on reports of 14,324 people who have side effects while taking Reclast from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Dec, 07, 2022

14,324 people reported to have side effects when taking Reclast.
Among them, 5 people (0.03%) have Dermatitis allergic.


What is Reclast?

Reclast has active ingredients of zoledronic acid. It is often used in osteoporosis. eHealthMe is studying from 14,628 Reclast users for its effectiveness, alternative drugs and more.

What is Dermatitis allergic?

Dermatitis allergic (inflammation of the skin due allergic reaction) is found to be associated with 1,226 drugs and 734 conditions by eHealthMe.

Number of Reclast and Dermatitis allergic reports submitted per year:

Could Reclast cause Dermatitis allergic?

Time on Reclast when people have Dermatitis allergic *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 100 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Dermatitis allergic when taking Reclast *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Dermatitis allergic when taking Reclast *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 100 %
  • 60+: 0.0 %

Common drugs people take besides Reclast *:

  1. Zocor: 2 people, 40.00%
  2. Vicodin: 2 people, 40.00%
  3. Oxycontin: 2 people, 40.00%
  4. Fosamax: 2 people, 40.00%
  5. Tylenol: 1 person, 20.00%
  6. Tramadol Hydrochloride: 1 person, 20.00%
  7. Prednisone: 1 person, 20.00%
  8. Oxycodone: 1 person, 20.00%
  9. Methotrexate: 1 person, 20.00%
  10. Hemp: 1 person, 20.00%

Common side effects people have besides Dermatitis allergic *:

  1. Weight Decreased: 2 people, 40.00%
  2. Foot Deformity (functional disability of foot): 2 people, 40.00%
  3. Device Failure: 2 people, 40.00%
  4. Dizziness: 2 people, 40.00%
  5. Drowsiness: 2 people, 40.00%
  6. Drug Dependence: 2 people, 40.00%
  7. Drug Ineffective: 2 people, 40.00%
  8. Dyslipidaemia (abnormal amount of lipids): 2 people, 40.00%
  9. Fainting (loss of consciousness and postural tone): 2 people, 40.00%
  10. Fall: 2 people, 40.00%

Common conditions people have *:

  1. Polymyalgia Rheumatica (pain in many muscles): 2 people, 40.00%
  2. Back Pain: 2 people, 40.00%

* Approximation only. Some reports may have incomplete information.

Do you take Reclast and have Dermatitis allergic?

Check whether Dermatitis allergic is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Dermatitis allergic and when was it recovered:

Expand to all the drugs that have ingredients of zoledronic acid:

Alternative drugs to, pros and cons of Reclast:

Common Reclast side effects:

Browse all side effects of Reclast:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Dermatitis allergic treatments and more:

COVID vaccines that are related to Dermatitis allergic:

Common drugs associated with Dermatitis allergic:

All the drugs that are associated with Dermatitis allergic:

Common conditions associated with Dermatitis allergic:

All the conditions that are associated with Dermatitis allergic:

How the study uses the data?

The study uses data from the FDA. It is based on zoledronic acid (the active ingredients of Reclast) and Reclast (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: